Compare INDV & SAIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INDV | SAIC |
|---|---|---|
| Founded | N/A | 1969 |
| Country | United States | United States |
| Employees | 838 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.3B |
| IPO Year | 2014 | 2013 |
| Metric | INDV | SAIC |
|---|---|---|
| Price | $37.58 | $99.79 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $110.50 |
| AVG Volume (30 Days) | ★ 2.0M | 415.4K |
| Earning Date | 06-08-2026 | 06-01-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | ★ 8100.00 | 7.39 |
| EPS | 0.69 | ★ 7.70 |
| Revenue | $1,239,000,000.00 | ★ $7,262,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.65 |
| P/E Ratio | $54.72 | ★ $12.48 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $11.49 | $81.08 |
| 52 Week High | $41.00 | $121.05 |
| Indicator | INDV | SAIC |
|---|---|---|
| Relative Strength Index (RSI) | 58.25 | 62.09 |
| Support Level | $29.71 | $90.65 |
| Resistance Level | $37.83 | $103.17 |
| Average True Range (ATR) | 1.15 | 3.38 |
| MACD | -0.32 | 0.56 |
| Stochastic Oscillator | 35.77 | 99.45 |
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.